---
description: 阿尔茨海默氏症的环境风险因素数据库
---

# 介绍



| id.exposure | id.outcome | outcome | exposure | method | nsnp | b | se | pval |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 297 | 297 | Alzheimer's disease - id:297 | Alzheimer's disease - id:297 | Inverse variance weighted | 14 | 1.000 | 0.035 | 1.130E-179 |
| 298 | 297 | Alzheimer's disease - id:297 | Alzheimer's disease - id:298 | Inverse variance weighted | 20 | 0.976 | 0.036 | 3.948E-166 |
| 1001 | 297 | Alzheimer's disease - id:297 | Years of schooling - id:1001 | Inverse variance weighted | 64 | -0.529 | 0.139 | 1.449E-04 |
| 89 | 297 | Alzheimer's disease - id:297 | Height - id:89 | Inverse variance weighted | 321 | -0.116 | 0.038 | 0.002 |
| 417 | 297 | Alzheimer's disease - id:297 | Myo-inositol - id:417 | Inverse variance weighted | 2 | 3.542 | 1.229 | 0.004 |
| 526 | 297 | Alzheimer's disease - id:297 | HWESASXX\* - id:526 | Inverse variance weighted | 2 | 0.759 | 0.277 | 0.006 |
| 54 | 297 | Alzheimer's disease - id:297 | Hip circumference - id:54 | Inverse variance weighted | 68 | -0.225 | 0.086 | 0.008 |
| 853 | 297 | Alzheimer's disease - id:297 | Free cholesterol to esterified cholesterol ratio - id:853 | Inverse variance weighted | 8 | 0.378 | 0.147 | 0.010 |
| 781 | 297 | Alzheimer's disease - id:297 | LDL cholesterol - id:781 | Inverse variance weighted | 36 | 0.366 | 0.149 | 0.014 |
| 860 | 297 | Alzheimer's disease - id:297 | Glutamine - id:860 | Inverse variance weighted | 5 | -0.192 | 0.078 | 0.014 |
| 55 | 297 | Alzheimer's disease - id:297 | Hip circumference - id:55 | Inverse variance weighted | 68 | -0.214 | 0.088 | 0.015 |
| 1055 | 297 | Alzheimer's disease - id:297 | Urate - id:1055 | Inverse variance weighted | 24 | 0.088 | 0.038 | 0.019 |
| 721 | 297 | Alzheimer's disease - id:297 | X-14208--phenylalanylserine - id:721 | Inverse variance weighted | 2 | -0.517 | 0.221 | 0.019 |
| 1045 | 297 | Alzheimer's disease - id:297 | Hippocampus volume - id:1045 | Inverse variance weighted | 2 | 0.001 | 0.000 | 0.019 |
| 1015 | 297 | Alzheimer's disease - id:297 | C-reactive protein - id:1015 | Inverse variance weighted | 3 | 0.245 | 0.108 | 0.023 |
| 359 | 297 | Alzheimer's disease - id:297 | Gamma-glutamylglutamine - id:359 | Inverse variance weighted | 3 | -1.429 | 0.655 | 0.029 |
| 301 | 297 | Alzheimer's disease - id:297 | Total cholesterol - id:301 | Inverse variance weighted | 80 | 0.254 | 0.120 | 0.034 |
| 1142 | 297 | Alzheimer's disease - id:297 | Linoleic acid \(18:2n6\) - id:1142 | Inverse variance weighted | 71 | -0.002 | 0.001 | 0.036 |
| 627 | 297 | Alzheimer's disease - id:297 | Epiandrosterone sulfate - id:627 | Inverse variance weighted | 2 | -0.410 | 0.202 | 0.042 |
| 1073 | 297 | Alzheimer's disease - id:297 | Copper - id:1073 | Inverse variance weighted | 2 | -0.145 | 0.073 | 0.046 |
| 341 | 297 | Alzheimer's disease - id:297 | Citrate - id:341 | Inverse variance weighted | 6 | -1.156 | 0.581 | 0.047 |
| 757 | 297 | Alzheimer's disease - id:297 | Fasting glucose - id:757 | Inverse variance weighted | 9 | 0.413 | 0.210 | 0.050 |
| 849 | 297 | Alzheimer's disease - id:297 | Citrate - id:849 | Inverse variance weighted | 4 | -0.189 | 0.097 | 0.052 |
| 48 | 297 | Alzheimer's disease - id:297 | Hip circumference - id:48 | Inverse variance weighted | 47 | -0.225 | 0.116 | 0.053 |
| 782 | 297 | Alzheimer's disease - id:297 | Total cholesterol - id:782 | Inverse variance weighted | 40 | 0.336 | 0.178 | 0.058 |
| 842 | 297 | Alzheimer's disease - id:297 | Apolipoprotein A-I - id:842 | Inverse variance weighted | 9 | -0.149 | 0.080 | 0.064 |
| 355 | 297 | Alzheimer's disease - id:297 | Proline - id:355 | Inverse variance weighted | 2 | -0.699 | 0.377 | 0.064 |
| 350 | 297 | Alzheimer's disease - id:297 | Laurate \(12:0\) - id:350 | Inverse variance weighted | 2 | 2.103 | 1.155 | 0.069 |
| 795 | 297 | Alzheimer's disease - id:297 | Urate - id:795 | Inverse variance weighted | 4 | 0.097 | 0.055 | 0.076 |
| 10 | 297 | Alzheimer's disease - id:297 | Crohn's disease - id:10 | Inverse variance weighted | 98 | -0.029 | 0.016 | 0.077 |
| 270 | 297 | Alzheimer's disease - id:297 | Haemoglobin concentration - id:270 | Inverse variance weighted | 15 | -0.176 | 0.101 | 0.082 |
| 49 | 297 | Alzheimer's disease - id:297 | Hip circumference - id:49 | Inverse variance weighted | 52 | -0.183 | 0.106 | 0.086 |
| 684 | 297 | Alzheimer's disease - id:297 | X-13431--nonanoylcarnitine\* - id:684 | Inverse variance weighted | 2 | -0.310 | 0.181 | 0.087 |
| 1112 | 297 | Alzheimer's disease - id:297 | Primary sclerosing cholangitis  - id:1112 | Inverse variance weighted | 14 | -0.040 | 0.024 | 0.088 |
| 843 | 297 | Alzheimer's disease - id:297 | Apolipoprotein B - id:843 | Inverse variance weighted | 13 | 0.450 | 0.267 | 0.092 |
| 300 | 297 | Alzheimer's disease - id:297 | LDL cholesterol - id:300 | Inverse variance weighted | 72 | 0.170 | 0.102 | 0.094 |
| 573 | 297 | Alzheimer's disease - id:297 | Isobutyrylcarnitine - id:573 | Inverse variance weighted | 2 | -0.724 | 0.436 | 0.097 |
| 12 | 297 | Alzheimer's disease - id:297 | Crohn's disease - id:12 | Inverse variance weighted | 109 | -0.028 | 0.017 | 0.097 |
| 616 | 297 | Alzheimer's disease - id:297 | Alpha-hydroxyisovalerate - id:616 | Inverse variance weighted | 3 | -0.570 | 0.349 | 0.103 |
| 460 | 297 | Alzheimer's disease - id:297 | Androsterone sulfate - id:460 | Inverse variance weighted | 3 | -0.168 | 0.103 | 0.103 |
| 777 | 297 | Alzheimer's disease - id:297 | Fasting glucose - id:777 | Inverse variance weighted | 32 | 0.253 | 0.159 | 0.113 |
| 755 | 297 | Alzheimer's disease - id:297 | Years of schooling - id:755 | Inverse variance weighted | 4 | -0.493 | 0.315 | 0.117 |
| 858 | 297 | Alzheimer's disease - id:297 | Free cholesterol - id:858 | Inverse variance weighted | 8 | 0.275 | 0.176 | 0.118 |
| 816 | 297 | Alzheimer's disease - id:297 | Neuroblastoma - id:816 | Inverse variance weighted | 3 | -0.063 | 0.041 | 0.120 |
| 856 | 297 | Alzheimer's disease - id:297 | Omega-6 fatty acids - id:856 | Inverse variance weighted | 7 | 0.345 | 0.224 | 0.123 |
| 1059 | 297 | Alzheimer's disease - id:297 | Celiac disease - id:1059 | Inverse variance weighted | 11 | -0.038 | 0.025 | 0.127 |
| 331 | 297 | Alzheimer's disease - id:297 | Stearate \(18:0\) - id:331 | Inverse variance weighted | 2 | -1.165 | 0.763 | 0.127 |
| 640 | 297 | Alzheimer's disease - id:297 | X-12696 - id:640 | Inverse variance weighted | 2 | -0.773 | 0.506 | 0.127 |
| 482 | 297 | Alzheimer's disease - id:297 | 10-undecenoate \(11:1n1\) - id:482 | Inverse variance weighted | 2 | -0.523 | 0.347 | 0.132 |
| 484 | 297 | Alzheimer's disease - id:297 | X-11204 - id:484 | Inverse variance weighted | 2 | -1.827 | 1.214 | 0.132 |
| 758 | 297 | Alzheimer's disease - id:297 | HbA1C - id:758 | Inverse variance weighted | 11 | 0.239 | 0.159 | 0.133 |
| 746 | 297 | Alzheimer's disease - id:297 | 5alpha-androstan-3beta,17beta-diol disulfate - id:746 | Inverse variance weighted | 3 | -0.213 | 0.144 | 0.138 |
| 373 | 297 | Alzheimer's disease - id:297 | X-03094 - id:373 | Inverse variance weighted | 3 | -1.041 | 0.703 | 0.139 |
| 679 | 297 | Alzheimer's disease - id:297 | N2,N2-dimethylguanosine - id:679 | Inverse variance weighted | 2 | 1.532 | 1.040 | 0.141 |
| 776 | 297 | Alzheimer's disease - id:297 | 2hr glucose - id:776 | Inverse variance weighted | 7 | 0.117 | 0.079 | 0.141 |
| 433 | 297 | Alzheimer's disease - id:297 | Levulinate \(4-oxovalerate\) - id:433 | Inverse variance weighted | 2 | -1.478 | 1.005 | 0.141 |
| 500 | 297 | Alzheimer's disease - id:297 | 3-dehydrocarnitine\* - id:500 | Inverse variance weighted | 3 | -0.716 | 0.489 | 0.143 |
| 719 | 297 | Alzheimer's disease - id:297 | X-14189--leucylalanine - id:719 | Inverse variance weighted | 2 | -0.545 | 0.373 | 0.144 |
| 893 | 297 | Alzheimer's disease - id:297 | 18:2, linoleic acid \(LA\) - id:893 | Inverse variance weighted | 10 | 0.474 | 0.328 | 0.148 |
| 881 | 297 | Alzheimer's disease - id:297 | Cholesterol esters in large VLDL - id:881 | Inverse variance weighted | 17 | 0.184 | 0.128 | 0.150 |
| 498 | 297 | Alzheimer's disease - id:297 | X-11327 - id:498 | Inverse variance weighted | 2 | 1.697 | 1.189 | 0.153 |
| 883 | 297 | Alzheimer's disease - id:297 | Total lipids in large LDL - id:883 | Inverse variance weighted | 17 | 0.184 | 0.129 | 0.155 |
| 1084 | 297 | Alzheimer's disease - id:297 | Birth weight - id:1084 | Inverse variance weighted | 48 | -0.145 | 0.102 | 0.155 |
| 864 | 297 | Alzheimer's disease - id:297 | Total cholesterol in HDL - id:864 | Inverse variance weighted | 11 | -0.107 | 0.076 | 0.158 |
| 87 | 297 | Alzheimer's disease - id:297 | Extreme waist-to-hip ratio - id:87 | Inverse variance weighted | 2 | -0.083 | 0.059 | 0.163 |
| 302 | 297 | Alzheimer's disease - id:297 | Triglycerides - id:302 | Inverse variance weighted | 52 | 0.210 | 0.150 | 0.163 |
| 396 | 297 | Alzheimer's disease - id:297 | X-18601 - id:396 | Inverse variance weighted | 2 | -0.635 | 0.455 | 0.163 |
| 884 | 297 | Alzheimer's disease - id:297 | Concentration of large LDL particles - id:884 | Inverse variance weighted | 17 | 0.181 | 0.131 | 0.165 |
| 667 | 297 | Alzheimer's disease - id:297 | X-12850 - id:667 | Inverse variance weighted | 2 | -0.462 | 0.333 | 0.165 |
| 478 | 297 | Alzheimer's disease - id:297 | Dehydroisoandrosterone sulfate \(DHEA-S\) - id:478 | Inverse variance weighted | 2 | -0.614 | 0.444 | 0.167 |
| 602 | 297 | Alzheimer's disease - id:297 | 1-eicosatrienoylglycerophosphocholine\* - id:602 | Inverse variance weighted | 2 | -0.629 | 0.456 | 0.168 |
| 770 | 297 | Alzheimer's disease - id:297 | HOMA-B - id:770 | Inverse variance weighted | 2 | -0.516 | 0.375 | 0.169 |
| 356 | 297 | Alzheimer's disease - id:297 | Citrulline - id:356 | Inverse variance weighted | 3 | 1.357 | 0.994 | 0.172 |
| 722 | 297 | Alzheimer's disease - id:297 | X-14304--leucylalanine - id:722 | Inverse variance weighted | 2 | -0.578 | 0.425 | 0.174 |
| 1 | 297 | Alzheimer's disease - id:297 | Adiponectin - id:1 | Inverse variance weighted | 11 | -0.183 | 0.134 | 0.174 |
| 1141 | 297 | Alzheimer's disease - id:297 | Arachidonic acid \(20:4n6\) - id:1141 | Inverse variance weighted | 56 | 0.003 | 0.002 | 0.174 |
| 882 | 297 | Alzheimer's disease - id:297 | Free cholesterol in large LDL - id:882 | Inverse variance weighted | 14 | 0.194 | 0.144 | 0.178 |
| 541 | 297 | Alzheimer's disease - id:297 | X-11787 - id:541 | Inverse variance weighted | 2 | -0.518 | 0.388 | 0.182 |
| 778 | 297 | Alzheimer's disease - id:297 | Fasting insulin - id:778 | Inverse variance weighted | 14 | 0.386 | 0.290 | 0.184 |
| 880 | 297 | Alzheimer's disease - id:297 | Total cholesterol in large LDL - id:880 | Inverse variance weighted | 16 | 0.178 | 0.135 | 0.188 |
| 274 | 297 | Alzheimer's disease - id:297 | Packed cell volume - id:274 | Inverse variance weighted | 12 | -0.046 | 0.035 | 0.190 |
| 618 | 297 | Alzheimer's disease - id:297 | Decanoylcarnitine - id:618 | Inverse variance weighted | 3 | 0.280 | 0.213 | 0.190 |
| 712 | 297 | Alzheimer's disease - id:297 | Dihomo-linolenate \(20:3n3 or n6\) - id:712 | Inverse variance weighted | 2 | -0.701 | 0.543 | 0.196 |
| 803 | 297 | Alzheimer's disease - id:297 | PGC cross-disorder traits - id:803 | Inverse variance weighted | 4 | 0.139 | 0.108 | 0.197 |
| 1034 | 297 | Alzheimer's disease - id:297 | Height - id:1034 | Inverse variance weighted | 4 | -0.137 | 0.107 | 0.199 |
| 999 | 297 | Alzheimer's disease - id:297 | Body fat - id:999 | Inverse variance weighted | 9 | -3.779 | 2.942 | 0.199 |
| 276 | 297 | Alzheimer's disease - id:297 | Celiac disease - id:276 | Inverse variance weighted | 12 | -0.030 | 0.024 | 0.200 |
| 885 | 297 | Alzheimer's disease - id:297 | Phospholipids in large LDL - id:885 | Inverse variance weighted | 15 | 0.180 | 0.143 | 0.208 |
| 294 | 297 | Alzheimer's disease - id:297 | Inflammatory bowel disease - id:294 | Inverse variance weighted | 121 | -0.022 | 0.018 | 0.212 |
| 481 | 297 | Alzheimer's disease - id:297 | Caprylate \(8:0\) - id:481 | Inverse variance weighted | 2 | -1.452 | 1.168 | 0.214 |
| 72 | 297 | Alzheimer's disease - id:297 | Waist-to-hip ratio - id:72 | Inverse variance weighted | 29 | -0.170 | 0.137 | 0.215 |
| 615 | 297 | Alzheimer's disease - id:297 | Octanoylcarnitine - id:615 | Inverse variance weighted | 2 | 0.240 | 0.195 | 0.220 |
| 66 | 297 | Alzheimer's disease - id:297 | Waist circumference - id:66 | Inverse variance weighted | 59 | -0.119 | 0.099 | 0.227 |
| 299 | 297 | Alzheimer's disease - id:297 | HDL cholesterol - id:299 | Inverse variance weighted | 85 | -0.274 | 0.228 | 0.229 |
| 629 | 297 | Alzheimer's disease - id:297 | X-12510--2-aminooctanoic acid - id:629 | Inverse variance weighted | 3 | -0.203 | 0.170 | 0.233 |
| 773 | 297 | Alzheimer's disease - id:297 | Fasting glucose - id:773 | Inverse variance weighted | 19 | 0.233 | 0.196 | 0.235 |
| 32 | 297 | Alzheimer's disease - id:297 | Ulcerative colitis - id:32 | Inverse variance weighted | 33 | 0.032 | 0.027 | 0.237 |
| 292 | 297 | Alzheimer's disease - id:297 | Inflammatory bowel disease - id:292 | Inverse variance weighted | 109 | -0.023 | 0.020 | 0.242 |
| 1140 | 297 | Alzheimer's disease - id:297 | Dihomo-gamma-linolenic acid \(20:3n6\) - id:1140 | Inverse variance weighted | 66 | 0.005 | 0.004 | 0.244 |
| 1105 | 297 | Alzheimer's disease - id:297 | Serum creatinine \(eGFRcrea\) - id:1105 | Inverse variance weighted | 37 | 0.440 | 0.378 | 0.244 |
| 729 | 297 | Alzheimer's disease - id:297 | X-14626 - id:729 | Inverse variance weighted | 2 | 0.422 | 0.364 | 0.247 |
| 742 | 297 | Alzheimer's disease - id:297 | Succinylcarnitine - id:742 | Inverse variance weighted | 6 | -0.589 | 0.512 | 0.250 |
| 435 | 297 | Alzheimer's disease - id:297 | X-08988 - id:435 | Inverse variance weighted | 2 | -0.619 | 0.545 | 0.256 |
| 711 | 297 | Alzheimer's disease - id:297 | Hexadecanedioate - id:711 | Inverse variance weighted | 2 | 0.228 | 0.204 | 0.264 |
| 427 | 297 | Alzheimer's disease - id:297 | 2-hydroxyisobutyrate - id:427 | Inverse variance weighted | 3 | -0.560 | 0.507 | 0.269 |
| 656 | 297 | Alzheimer's disease - id:297 | Bradykinin, des-arg\(9\) - id:656 | Inverse variance weighted | 3 | -0.082 | 0.074 | 0.272 |
| 1024 | 297 | Alzheimer's disease - id:297 | Multiple sclerosis - id:1024 | Inverse variance weighted | 22 | -0.032 | 0.029 | 0.272 |
| 753 | 297 | Alzheimer's disease - id:297 | Cis-4-decenoyl carnitine - id:753 | Inverse variance weighted | 2 | 0.285 | 0.265 | 0.281 |
| 1085 | 297 | Alzheimer's disease - id:297 | Amyotrophic lateral sclerosis - id:1085 | Inverse variance weighted | 5 | 0.316 | 0.294 | 0.283 |
| 683 | 297 | Alzheimer's disease - id:297 | X-13429 - id:683 | Inverse variance weighted | 3 | 0.136 | 0.127 | 0.285 |
| 865 | 297 | Alzheimer's disease - id:297 | Mean diameter for HDL particles - id:865 | Inverse variance weighted | 9 | -0.150 | 0.140 | 0.286 |
| 862 | 297 | Alzheimer's disease - id:297 | Glycoproteins - id:862 | Inverse variance weighted | 10 | -0.036 | 0.034 | 0.288 |
| 867 | 297 | Alzheimer's disease - id:297 | Total cholesterol in IDL - id:867 | Inverse variance weighted | 14 | 0.158 | 0.149 | 0.289 |
| 426 | 297 | Alzheimer's disease - id:297 | X-08402 - id:426 | Inverse variance weighted | 2 | 0.308 | 0.291 | 0.290 |
| 30 | 297 | Alzheimer's disease - id:297 | Crohn's disease - id:30 | Inverse variance weighted | 45 | -0.018 | 0.017 | 0.291 |
| 444 | 297 | Alzheimer's disease - id:297 | X-10510 - id:444 | Inverse variance weighted | 3 | 0.440 | 0.419 | 0.295 |
| 1096 | 297 | Alzheimer's disease - id:297 | Childhood obesity - id:1096 | Inverse variance weighted | 5 | -0.047 | 0.045 | 0.297 |
| 868 | 297 | Alzheimer's disease - id:297 | Free cholesterol in IDL - id:868 | Inverse variance weighted | 14 | 0.159 | 0.154 | 0.302 |
| 871 | 297 | Alzheimer's disease - id:297 | Phospholipids in IDL - id:871 | Inverse variance weighted | 15 | 0.152 | 0.149 | 0.306 |
| 869 | 297 | Alzheimer's disease - id:297 | Total lipids in IDL - id:869 | Inverse variance weighted | 15 | 0.148 | 0.145 | 0.307 |
| 1104 | 297 | Alzheimer's disease - id:297 | Serum creatinine \(eGFRcrea\) - id:1104 | Inverse variance weighted | 37 | 0.419 | 0.415 | 0.313 |
| 836 | 297 | Alzheimer's disease - id:297 | College completion - id:836 | Inverse variance weighted | 3 | -0.166 | 0.167 | 0.319 |
| 675 | 297 | Alzheimer's disease - id:297 | X-13215 - id:675 | Inverse variance weighted | 2 | 0.923 | 0.931 | 0.321 |
| 79 | 297 | Alzheimer's disease - id:297 | Waist-to-hip ratio - id:79 | Inverse variance weighted | 35 | 0.117 | 0.118 | 0.324 |
| 11 | 297 | Alzheimer's disease - id:297 | Crohn's disease - id:11 | Inverse variance weighted | 9 | -0.015 | 0.015 | 0.328 |
| 859 | 297 | Alzheimer's disease - id:297 | Glucose - id:859 | Inverse variance weighted | 3 | 0.100 | 0.104 | 0.335 |
| 890 | 297 | Alzheimer's disease - id:297 | Concentration of large VLDL particles - id:890 | Inverse variance weighted | 8 | 0.490 | 0.509 | 0.336 |
| 1025 | 297 | Alzheimer's disease - id:297 | Multiple sclerosis - id:1025 | Inverse variance weighted | 37 | -0.023 | 0.024 | 0.336 |
| 6 | 297 | Alzheimer's disease - id:297 | Coronary heart disease - id:6 | Inverse variance weighted | 3 | 0.055 | 0.059 | 0.355 |
| 870 | 297 | Alzheimer's disease - id:297 | Concentration of IDL particles - id:870 | Inverse variance weighted | 13 | 0.147 | 0.162 | 0.364 |
| 360 | 297 | Alzheimer's disease - id:297 | Gamma-glutamyltyrosine - id:360 | Inverse variance weighted | 3 | 0.850 | 0.942 | 0.367 |
| 542 | 297 | Alzheimer's disease - id:297 | X-11792 - id:542 | Inverse variance weighted | 3 | -0.095 | 0.108 | 0.378 |
| 497 | 297 | Alzheimer's disease - id:297 | 1-linoleoylglycerophosphoethanolamine\* - id:497 | Inverse variance weighted | 2 | -0.300 | 0.341 | 0.379 |
| 23 | 297 | Alzheimer's disease - id:297 | Type 2 diabetes - id:23 | Inverse variance weighted | 25 | 0.043 | 0.050 | 0.381 |
| 531 | 297 | Alzheimer's disease - id:297 | X-11538 - id:531 | Inverse variance weighted | 3 | 0.139 | 0.159 | 0.384 |
| 661 | 297 | Alzheimer's disease - id:297 | X-12798 - id:661 | Inverse variance weighted | 3 | -0.114 | 0.131 | 0.386 |
| 779 | 297 | Alzheimer's disease - id:297 | Fasting insulin - id:779 | Inverse variance weighted | 14 | 0.244 | 0.284 | 0.391 |
| 419 | 297 | Alzheimer's disease - id:297 | 1,5-anhydroglucitol \(1,5-AG\) - id:419 | Inverse variance weighted | 3 | -0.364 | 0.424 | 0.391 |
| 841 | 297 | Alzheimer's disease - id:297 | Albumin - id:841 | Inverse variance weighted | 2 | 0.176 | 0.207 | 0.395 |
| 872 | 297 | Alzheimer's disease - id:297 | Triglycerides in IDL - id:872 | Inverse variance weighted | 13 | 0.254 | 0.299 | 0.396 |
| 429 | 297 | Alzheimer's disease - id:297 | 4-methyl-2-oxopentanoate - id:429 | Inverse variance weighted | 2 | 0.771 | 0.911 | 0.398 |
| 1008 | 297 | Alzheimer's disease - id:297 | Platelet count - id:1008 | Inverse variance weighted | 31 | -0.001 | 0.001 | 0.409 |
| 855 | 297 | Alzheimer's disease - id:297 | Omega-3 fatty acids - id:855 | Inverse variance weighted | 5 | 0.058 | 0.071 | 0.410 |
| 887 | 297 | Alzheimer's disease - id:297 | Cholesterol esters in large VLDL - id:887 | Inverse variance weighted | 8 | 0.836 | 1.022 | 0.413 |
| 25 | 297 | Alzheimer's disease - id:297 | Type 2 diabetes - id:25 | Inverse variance weighted | 19 | 0.043 | 0.053 | 0.416 |
| 1058 | 297 | Alzheimer's disease - id:297 | Celiac disease - id:1058 | Inverse variance weighted | 11 | -0.016 | 0.020 | 0.419 |
| 707 | 297 | Alzheimer's disease - id:297 | 1-palmitoylglycerophosphoethanolamine - id:707 | Inverse variance weighted | 2 | -0.799 | 0.993 | 0.421 |
| 469 | 297 | Alzheimer's disease - id:297 | Alanine - id:469 | Inverse variance weighted | 2 | -0.988 | 1.231 | 0.422 |
| 1056 | 297 | Alzheimer's disease - id:297 | Heart rate - id:1056 | Inverse variance weighted | 15 | 0.008 | 0.011 | 0.432 |
| 863 | 297 | Alzheimer's disease - id:297 | Glycoprotein acetyls - id:863 | Inverse variance weighted | 6 | 0.084 | 0.108 | 0.434 |
| 22 | 297 | Alzheimer's disease - id:297 | Schizophrenia - id:22 | Inverse variance weighted | 68 | 0.026 | 0.034 | 0.435 |
| 1150 | 297 | Alzheimer's disease - id:297 | cis-trans-18:2 - id:1150 | Inverse variance weighted | 2 | -2.011 | 2.576 | 0.435 |
| 501 | 297 | Alzheimer's disease - id:297 | Pyroglutamine\* - id:501 | Inverse variance weighted | 3 | 0.211 | 0.270 | 0.435 |
| 780 | 297 | Alzheimer's disease - id:297 | HDL cholesterol - id:780 | Inverse variance weighted | 40 | -0.080 | 0.103 | 0.437 |
| 889 | 297 | Alzheimer's disease - id:297 | Total lipids in large VLDL - id:889 | Inverse variance weighted | 7 | 1.000 | 1.289 | 0.438 |
| 1054 | 297 | Alzheimer's disease - id:297 | Gout - id:1054 | Inverse variance weighted | 2 | 0.023 | 0.030 | 0.438 |
| 709 | 297 | Alzheimer's disease - id:297 | Tetradecanedioate - id:709 | Inverse variance weighted | 2 | 0.137 | 0.178 | 0.442 |
| 1007 | 297 | Alzheimer's disease - id:297 | Neuroticism - id:1007 | Inverse variance weighted | 8 | -0.227 | 0.295 | 0.442 |
| 306 | 297 | Alzheimer's disease - id:297 | Leucine - id:306 | Inverse variance weighted | 12 | 0.648 | 0.847 | 0.444 |
| 519 | 297 | Alzheimer's disease - id:297 | X-11469 - id:519 | Inverse variance weighted | 3 | -0.171 | 0.225 | 0.446 |
| 29 | 297 | Alzheimer's disease - id:297 | Birth length - id:29 | Inverse variance weighted | 2 | -0.222 | 0.292 | 0.448 |
| 1086 | 297 | Alzheimer's disease - id:297 | Amyotrophic lateral sclerosis - id:1086 | Inverse variance weighted | 3 | 0.056 | 0.076 | 0.464 |
| 670 | 297 | Alzheimer's disease - id:297 | X-12855 - id:670 | Inverse variance weighted | 2 | -0.349 | 0.477 | 0.465 |
| 783 | 297 | Alzheimer's disease - id:297 | Triglycerides - id:783 | Inverse variance weighted | 26 | 0.155 | 0.217 | 0.474 |
| 857 | 297 | Alzheimer's disease - id:297 | Omega-9 and saturated fatty acids - id:857 | Inverse variance weighted | 4 | -0.057 | 0.082 | 0.485 |
| 837 | 297 | Alzheimer's disease - id:297 | Years of schooling - id:837 | Inverse variance weighted | 4 | -0.332 | 0.478 | 0.487 |
| 888 | 297 | Alzheimer's disease - id:297 | Free cholesterol in large VLDL - id:888 | Inverse variance weighted | 9 | 0.741 | 1.075 | 0.491 |
| 601 | 297 | Alzheimer's disease - id:297 | ADpSGEGDFXAEGGGVR\* - id:601 | Inverse variance weighted | 2 | 0.200 | 0.293 | 0.495 |
| 24 | 297 | Alzheimer's disease - id:297 | Type 2 diabetes - id:24 | Inverse variance weighted | 35 | 0.025 | 0.036 | 0.496 |
| 379 | 297 | Alzheimer's disease - id:297 | Carnitine - id:379 | Inverse variance weighted | 16 | -0.496 | 0.742 | 0.503 |
| 789 | 297 | Alzheimer's disease - id:297 | Urate - id:789 | Inverse variance weighted | 3 | 0.022 | 0.034 | 0.504 |
| 874 | 297 | Alzheimer's disease - id:297 | Total cholesterol in large HDL - id:874 | Inverse variance weighted | 11 | -0.471 | 0.710 | 0.507 |
| 774 | 297 | Alzheimer's disease - id:297 | Fasting insulin - id:774 | Inverse variance weighted | 4 | -0.924 | 1.408 | 0.512 |
| 378 | 297 | Alzheimer's disease - id:297 | Acetylphosphate - id:378 | Inverse variance weighted | 2 | -0.866 | 1.376 | 0.529 |
| 1006 | 297 | Alzheimer's disease - id:297 | Mean platelet volume - id:1006 | Inverse variance weighted | 22 | 0.210 | 0.334 | 0.530 |
| 634 | 297 | Alzheimer's disease - id:297 | 1-arachidonoylglycerophosphoinositol\* - id:634 | Inverse variance weighted | 2 | 0.271 | 0.432 | 0.531 |
| 761 | 297 | Alzheimer's disease - id:297 | Corrected insulin response - id:761 | Inverse variance weighted | 2 | 0.057 | 0.094 | 0.540 |
| 1083 | 297 | Alzheimer's disease - id:297 | Birth weight - id:1083 | Inverse variance weighted | 41 | -0.058 | 0.097 | 0.551 |
| 570 | 297 | Alzheimer's disease - id:297 | X-12063 - id:570 | Inverse variance weighted | 7 | -0.105 | 0.178 | 0.555 |
| 698 | 297 | Alzheimer's disease - id:297 | Hydroxyisovaleroyl carnitine - id:698 | Inverse variance weighted | 2 | -0.376 | 0.641 | 0.557 |
| 1158 | 297 | Alzheimer's disease - id:297 | Stearic acid \(18:0\) plasma levels - id:1158 | Inverse variance weighted | 2 | 0.039 | 0.067 | 0.559 |
| 876 | 297 | Alzheimer's disease - id:297 | Free cholesterol in large HDL - id:876 | Inverse variance weighted | 11 | -0.428 | 0.736 | 0.561 |
| 875 | 297 | Alzheimer's disease - id:297 | Cholesterol esters in large HDL - id:875 | Inverse variance weighted | 9 | -0.465 | 0.823 | 0.572 |
| 886 | 297 | Alzheimer's disease - id:297 | Total cholesterol in large VLDL - id:886 | Inverse variance weighted | 7 | 0.722 | 1.283 | 0.574 |
| 891 | 297 | Alzheimer's disease - id:297 | Phospholipids in large VLDL - id:891 | Inverse variance weighted | 7 | 0.753 | 1.339 | 0.574 |
| 1051 | 297 | Alzheimer's disease - id:297 | Transferrin Saturation - id:1051 | Inverse variance weighted | 3 | -0.025 | 0.045 | 0.579 |
| 325 | 297 | Alzheimer's disease - id:297 | Tyrosine - id:325 | Inverse variance weighted | 3 | -0.865 | 1.564 | 0.580 |
| 1049 | 297 | Alzheimer's disease - id:297 | Iron - id:1049 | Inverse variance weighted | 3 | -0.032 | 0.059 | 0.582 |
| 479 | 297 | Alzheimer's disease - id:297 | Propionylcarnitine - id:479 | Inverse variance weighted | 3 | 0.459 | 0.840 | 0.585 |
| 892 | 297 | Alzheimer's disease - id:297 | Triglycerides in large VLDL - id:892 | Inverse variance weighted | 7 | 0.720 | 1.320 | 0.585 |
| 850 | 297 | Alzheimer's disease - id:297 | Creatinine - id:850 | Inverse variance weighted | 5 | -0.099 | 0.181 | 0.586 |
| 463 | 297 | Alzheimer's disease - id:297 | Acetylcarnitine - id:463 | Inverse variance weighted | 2 | -0.362 | 0.664 | 0.586 |
| 78 | 297 | Alzheimer's disease - id:297 | Waist-to-hip ratio - id:78 | Inverse variance weighted | 35 | 0.060 | 0.112 | 0.590 |
| 834 | 297 | Alzheimer's disease - id:297 | Rheumatoid arthritis - id:834 | Inverse variance weighted | 6 | 0.015 | 0.027 | 0.594 |
| 8 | 297 | Alzheimer's disease - id:297 | Coronary heart disease - id:8 | Inverse variance weighted | 13 | -0.022 | 0.042 | 0.596 |
| 316 | 297 | Alzheimer's disease - id:297 | Uridine - id:316 | Inverse variance weighted | 3 | -0.560 | 1.058 | 0.597 |
| 1156 | 297 | Alzheimer's disease - id:297 | palmitoleic acid \(16:1n7\) - id:1156 | Inverse variance weighted | 5 | 0.237 | 0.452 | 0.600 |
| 693 | 297 | Alzheimer's disease - id:297 | X-13548 - id:693 | Inverse variance weighted | 2 | -0.593 | 1.135 | 0.601 |
| 691 | 297 | Alzheimer's disease - id:297 | X-13496 - id:691 | Inverse variance weighted | 2 | -0.665 | 1.289 | 0.606 |
| 775 | 297 | Alzheimer's disease - id:297 | Fasting insulin - id:775 | Inverse variance weighted | 4 | 0.234 | 0.458 | 0.609 |
| 844 | 297 | Alzheimer's disease - id:297 | Ratio of bisallylic groups to double bonds - id:844 | Inverse variance weighted | 5 | 0.026 | 0.051 | 0.614 |
| 1060 | 297 | Alzheimer's disease - id:297 | Celiac disease - id:1060 | Inverse variance weighted | 7 | -0.015 | 0.031 | 0.618 |
| 847 | 297 | Alzheimer's disease - id:297 | Average number of methylene groups per double bond - id:847 | Inverse variance weighted | 5 | -0.114 | 0.231 | 0.622 |
| 26 | 297 | Alzheimer's disease - id:297 | Type 2 diabetes - id:26 | Inverse variance weighted | 10 | 0.027 | 0.055 | 0.623 |
| 636 | 297 | Alzheimer's disease - id:297 | X-12644 - id:636 | Inverse variance weighted | 3 | -0.474 | 0.967 | 0.624 |
| 558 | 297 | Alzheimer's disease - id:297 | 1-arachidonoylglycerophosphocholine\* - id:558 | Inverse variance weighted | 3 | 0.135 | 0.279 | 0.629 |
| 495 | 297 | Alzheimer's disease - id:297 | X-11315 - id:495 | Inverse variance weighted | 3 | 0.217 | 0.451 | 0.630 |
| 1139 | 297 | Alzheimer's disease - id:297 | Gamma-linolenic acid \(18:3n6\) - id:1139 | Inverse variance weighted | 167 | 0.013 | 0.026 | 0.631 |
| 86 | 297 | Alzheimer's disease - id:297 | Extreme height - id:86 | Inverse variance weighted | 42 | -0.007 | 0.015 | 0.633 |
| 27 | 297 | Alzheimer's disease - id:297 | Birth weight - id:27 | Inverse variance weighted | 4 | -0.110 | 0.232 | 0.633 |
| 307 | 297 | Alzheimer's disease - id:297 | Cholesterol - id:307 | Inverse variance weighted | 2 | -0.471 | 1.027 | 0.646 |
| 543 | 297 | Alzheimer's disease - id:297 | X-11793--oxidized bilirubin\* - id:543 | Inverse variance weighted | 2 | 0.079 | 0.173 | 0.647 |
| 1102 | 297 | Alzheimer's disease - id:297 | Chronic kidney disease - id:1102 | Inverse variance weighted | 4 | 0.028 | 0.062 | 0.652 |
| 383 | 297 | Alzheimer's disease - id:297 | 3-methyl-2-oxovalerate - id:383 | Inverse variance weighted | 3 | 0.368 | 0.826 | 0.656 |
| 1087 | 297 | Alzheimer's disease - id:297 | Chronotype - id:1087 | Inverse variance weighted | 8 | 0.157 | 0.357 | 0.660 |
| 735 | 297 | Alzheimer's disease - id:297 | Octadecanedioate - id:735 | Inverse variance weighted | 2 | 0.168 | 0.388 | 0.665 |
| 812 | 297 | Alzheimer's disease - id:297 | Parkinson's disease - id:812 | Inverse variance weighted | 4 | 0.026 | 0.060 | 0.672 |
| 60 | 297 | Alzheimer's disease - id:297 | Waist circumference - id:60 | Inverse variance weighted | 44 | -0.054 | 0.129 | 0.673 |
| 848 | 297 | Alzheimer's disease - id:297 | Average number of methylene groups in a fatty acid chain - id:848 | Inverse variance weighted | 3 | -0.186 | 0.441 | 0.674 |
| 1047 | 297 | Alzheimer's disease - id:297 | Putamen volume - id:1047 | Inverse variance weighted | 4 | 0.000 | 0.000 | 0.678 |
| 747 | 297 | Alzheimer's disease - id:297 | 4-androsten-3beta,17beta-diol disulfate 1\* - id:747 | Inverse variance weighted | 2 | -0.111 | 0.269 | 0.680 |
| 877 | 297 | Alzheimer's disease - id:297 | Total lipids in large HDL - id:877 | Inverse variance weighted | 7 | -0.367 | 0.893 | 0.681 |
| 509 | 297 | Alzheimer's disease - id:297 | X-11423--O-sulfo-L-tyrosine - id:509 | Inverse variance weighted | 2 | -0.332 | 0.810 | 0.682 |
| 879 | 297 | Alzheimer's disease - id:297 | Phospholipids in large HDL - id:879 | Inverse variance weighted | 7 | -0.381 | 0.930 | 0.682 |
| 588 | 297 | Alzheimer's disease - id:297 | X-12189 - id:588 | Inverse variance weighted | 2 | 0.034 | 0.082 | 0.684 |
| 665 | 297 | Alzheimer's disease - id:297 | X-12844 - id:665 | Inverse variance weighted | 3 | -0.289 | 0.711 | 0.684 |
| 878 | 297 | Alzheimer's disease - id:297 | Concentration of large HDL particles - id:878 | Inverse variance weighted | 7 | -0.362 | 0.890 | 0.685 |
| 67 | 297 | Alzheimer's disease - id:297 | Waist circumference - id:67 | Inverse variance weighted | 60 | -0.041 | 0.102 | 0.689 |
| 652 | 297 | Alzheimer's disease - id:297 | Isovalerylcarnitine - id:652 | Inverse variance weighted | 3 | -0.118 | 0.298 | 0.692 |
| 1070 | 297 | Alzheimer's disease - id:297 | Sitting height ratio - id:1070 | Inverse variance weighted | 4 | -0.051 | 0.130 | 0.694 |
| 1144 | 297 | Alzheimer's disease - id:297 | Docosapentaenoic acid \(22:5n3\) - id:1144 | Inverse variance weighted | 3 | 0.072 | 0.188 | 0.700 |
| 7 | 297 | Alzheimer's disease - id:297 | Coronary heart disease - id:7 | Inverse variance weighted | 37 | 0.098 | 0.260 | 0.707 |
| 467 | 297 | Alzheimer's disease - id:297 | Hexanoylcarnitine - id:467 | Inverse variance weighted | 3 | 0.121 | 0.324 | 0.709 |
| 572 | 297 | Alzheimer's disease - id:297 | Gamma-glutamylphenylalanine - id:572 | Inverse variance weighted | 2 | 0.526 | 1.418 | 0.710 |
| 633 | 297 | Alzheimer's disease - id:297 | X-12556 - id:633 | Inverse variance weighted | 2 | -0.224 | 0.610 | 0.713 |
| 536 | 297 | Alzheimer's disease - id:297 | X-11593--O-methylascorbate\* - id:536 | Inverse variance weighted | 6 | 0.106 | 0.292 | 0.716 |
| 61 | 297 | Alzheimer's disease - id:297 | Waist circumference - id:61 | Inverse variance weighted | 39 | -0.052 | 0.146 | 0.720 |
| 271 | 297 | Alzheimer's disease - id:297 | Mean cell haemoglobin - id:271 | Inverse variance weighted | 30 | 0.010 | 0.030 | 0.725 |
| 845 | 297 | Alzheimer's disease - id:297 | Ratio of bisallylic groups to total fatty acids - id:845 | Inverse variance weighted | 5 | 0.017 | 0.047 | 0.725 |
| 1088 | 297 | Alzheimer's disease - id:297 | Sleep duration - id:1088 | Inverse variance weighted | 2 | -0.135 | 0.392 | 0.730 |
| 31 | 297 | Alzheimer's disease - id:297 | Inflammatory bowel disease - id:31 | Inverse variance weighted | 56 | -0.008 | 0.023 | 0.733 |
| 449 | 297 | Alzheimer's disease - id:297 | N-acetylglycine - id:449 | Inverse variance weighted | 2 | -0.094 | 0.278 | 0.735 |
| 349 | 297 | Alzheimer's disease - id:297 | Heptanoate \(7:0\) - id:349 | Inverse variance weighted | 2 | 0.371 | 1.107 | 0.738 |
| 1052 | 297 | Alzheimer's disease - id:297 | Transferrin - id:1052 | Inverse variance weighted | 7 | 0.010 | 0.032 | 0.739 |
| 832 | 297 | Alzheimer's disease - id:297 | Rheumatoid arthritis - id:832 | Inverse variance weighted | 34 | 0.008 | 0.024 | 0.748 |
| 798 | 297 | Alzheimer's disease - id:297 | Myocardial infarction - id:798 | Inverse variance weighted | 23 | 0.036 | 0.113 | 0.749 |
| 815 | 297 | Alzheimer's disease - id:297 | Systemic lupus erythematosus - id:815 | Inverse variance weighted | 2 | -0.011 | 0.036 | 0.754 |
| 275 | 297 | Alzheimer's disease - id:297 | Red blood cell count - id:275 | Inverse variance weighted | 25 | -0.072 | 0.230 | 0.755 |
| 792 | 297 | Alzheimer's disease - id:297 | Urate - id:792 | Inverse variance weighted | 3 | 0.004 | 0.014 | 0.759 |
| 464 | 297 | Alzheimer's disease - id:297 | Serine - id:464 | Inverse variance weighted | 3 | 0.155 | 0.520 | 0.766 |
| 517 | 297 | Alzheimer's disease - id:297 | X-11445--5-alpha-pregnan-3beta,20alpha-disulfate - id:517 | Inverse variance weighted | 4 | 0.046 | 0.155 | 0.767 |
| 524 | 297 | Alzheimer's disease - id:297 | X-11491 - id:524 | Inverse variance weighted | 3 | 0.071 | 0.248 | 0.776 |
| 835 | 297 | Alzheimer's disease - id:297 | Body mass index - id:835 | Inverse variance weighted | 65 | 0.030 | 0.106 | 0.776 |
| 699 | 297 | Alzheimer's disease - id:297 | Glutaroyl carnitine - id:699 | Inverse variance weighted | 7 | 0.072 | 0.255 | 0.778 |
| 1147 | 297 | Alzheimer's disease - id:297 | Eicosapentaenoic acid \(20:5n3\) - id:1147 | Inverse variance weighted | 2 | 0.026 | 0.092 | 0.782 |
| 471 | 297 | Alzheimer's disease - id:297 | 2-aminobutyrate - id:471 | Inverse variance weighted | 2 | 0.212 | 0.771 | 0.784 |
| 748 | 297 | Alzheimer's disease - id:297 | 4-androsten-3beta,17beta-diol disulfate 2\* - id:748 | Inverse variance weighted | 2 | 0.093 | 0.340 | 0.784 |
| 682 | 297 | Alzheimer's disease - id:297 | 1-arachidonoylglycerophosphoethanolamine\* - id:682 | Inverse variance weighted | 2 | -0.297 | 1.097 | 0.787 |
| 800 | 297 | Alzheimer's disease - id:297 | Bipolar disorder - id:800 | Inverse variance weighted | 4 | -0.016 | 0.059 | 0.790 |
| 801 | 297 | Alzheimer's disease - id:297 | Bipolar disorder - id:801 | Inverse variance weighted | 4 | -0.016 | 0.059 | 0.790 |
| 613 | 297 | Alzheimer's disease - id:297 | X-12456 - id:613 | Inverse variance weighted | 2 | 0.064 | 0.239 | 0.790 |
| 580 | 297 | Alzheimer's disease - id:297 | X-12092 - id:580 | Inverse variance weighted | 4 | -0.026 | 0.099 | 0.794 |
| 769 | 297 | Alzheimer's disease - id:297 | Fasting proinsulin - id:769 | Inverse variance weighted | 6 | 0.024 | 0.095 | 0.798 |
| 85 | 297 | Alzheimer's disease - id:297 | Extreme body mass index - id:85 | Inverse variance weighted | 7 | 0.014 | 0.054 | 0.801 |
| 476 | 297 | Alzheimer's disease - id:297 | Butyrylcarnitine - id:476 | Inverse variance weighted | 5 | 0.023 | 0.096 | 0.813 |
| 73 | 297 | Alzheimer's disease - id:297 | Waist-to-hip ratio - id:73 | Inverse variance weighted | 28 | -0.034 | 0.147 | 0.819 |
| 44 | 297 | Alzheimer's disease - id:297 | Asthma - id:44 | Inverse variance weighted | 7 | 0.010 | 0.044 | 0.825 |
| 630 | 297 | Alzheimer's disease - id:297 | X-12524 - id:630 | Inverse variance weighted | 2 | 0.295 | 1.403 | 0.834 |
| 840 | 297 | Alzheimer's disease - id:297 | Alanine - id:840 | Inverse variance weighted | 5 | -0.045 | 0.217 | 0.835 |
| 339 | 297 | Alzheimer's disease - id:297 | 4-acetamidobutanoate - id:339 | Inverse variance weighted | 2 | 0.119 | 0.574 | 0.835 |
| 1106 | 297 | Alzheimer's disease - id:297 | Serum cystatin C \(eGFRcys\) - id:1106 | Inverse variance weighted | 5 | -0.053 | 0.259 | 0.837 |
| 638 | 297 | Alzheimer's disease - id:297 | Asparagine - id:638 | Inverse variance weighted | 2 | 0.116 | 0.572 | 0.840 |
| 751 | 297 | Alzheimer's disease - id:297 | Palmitoyl sphingomyelin - id:751 | Inverse variance weighted | 2 | -0.195 | 1.011 | 0.847 |
| 1079 | 297 | Alzheimer's disease - id:297 | Zinc - id:1079 | Inverse variance weighted | 2 | -0.014 | 0.076 | 0.853 |
| 866 | 297 | Alzheimer's disease - id:297 | Histidine - id:866 | Inverse variance weighted | 3 | 0.021 | 0.120 | 0.858 |
| 852 | 297 | Alzheimer's disease - id:297 | 22:6, docosahexaenoic acid - id:852 | Inverse variance weighted | 4 | 0.017 | 0.100 | 0.864 |
| 596 | 297 | Alzheimer's disease - id:297 | X-12244--N-acetylcarnosine - id:596 | Inverse variance weighted | 3 | -0.097 | 0.605 | 0.872 |
| 1050 | 297 | Alzheimer's disease - id:297 | Ferritin - id:1050 | Inverse variance weighted | 4 | 0.027 | 0.177 | 0.877 |
| 304 | 297 | Alzheimer's disease - id:297 | Tryptophan - id:304 | Inverse variance weighted | 17 | 0.139 | 0.963 | 0.885 |
| 273 | 297 | Alzheimer's disease - id:297 | Mean cell volume - id:273 | Inverse variance weighted | 38 | 0.002 | 0.012 | 0.892 |
| 851 | 297 | Alzheimer's disease - id:297 | Average number of double bonds in a fatty acid chain - id:851 | Inverse variance weighted | 5 | 0.007 | 0.060 | 0.901 |
| 2 | 297 | Alzheimer's disease - id:297 | Body mass index - id:2 | Inverse variance weighted | 75 | -0.011 | 0.096 | 0.906 |
| 539 | 297 | Alzheimer's disease - id:297 | ADSGEGDFXAEGGGVR\* - id:539 | Inverse variance weighted | 2 | -0.019 | 0.166 | 0.908 |
| 272 | 297 | Alzheimer's disease - id:297 | Mean cell haemoglobin concentration - id:272 | Inverse variance weighted | 13 | -0.040 | 0.397 | 0.919 |
| 578 | 297 | Alzheimer's disease - id:297 | Erythronate\* - id:578 | Inverse variance weighted | 3 | 0.154 | 1.608 | 0.923 |
| 485 | 297 | Alzheimer's disease - id:297 | X-02269 - id:485 | Inverse variance weighted | 2 | 0.022 | 0.254 | 0.929 |
| 831 | 297 | Alzheimer's disease - id:297 | Rheumatoid arthritis - id:831 | Inverse variance weighted | 7 | -0.003 | 0.038 | 0.934 |
| 833 | 297 | Alzheimer's disease - id:297 | Rheumatoid arthritis - id:833 | Inverse variance weighted | 43 | 0.002 | 0.022 | 0.937 |
| 513 | 297 | Alzheimer's disease - id:297 | X-11440 - id:513 | Inverse variance weighted | 3 | -0.016 | 0.224 | 0.943 |
| 685 | 297 | Alzheimer's disease - id:297 | X-13435 - id:685 | Inverse variance weighted | 2 | 0.027 | 0.422 | 0.948 |
| 587 | 297 | Alzheimer's disease - id:297 | X-12188 - id:587 | Inverse variance weighted | 2 | 0.006 | 0.097 | 0.952 |
| 293 | 297 | Alzheimer's disease - id:297 | Inflammatory bowel disease - id:293 | Inverse variance weighted | 7 | 0.001 | 0.019 | 0.956 |
| 375 | 297 | Alzheimer's disease - id:297 | Kynurenine - id:375 | Inverse variance weighted | 3 | -0.029 | 0.990 | 0.977 |
| 646 | 297 | Alzheimer's disease - id:297 | X-12728 - id:646 | Inverse variance weighted | 4 | 0.001 | 0.040 | 0.977 |
| 362 | 297 | Alzheimer's disease - id:297 | Betaine - id:362 | Inverse variance weighted | 3 | -0.015 | 0.552 | 0.978 |
| 560 | 297 | Alzheimer's disease - id:297 | X-11905 - id:560 | Inverse variance weighted | 2 | 0.006 | 0.397 | 0.987 |
| 528 | 297 | Alzheimer's disease - id:297 | X-11529 - id:528 | Inverse variance weighted | 2 | -0.001 | 0.157 | 0.994 |

